A detailed history of Wellington Management Group LLP transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 167,831 shares of ALXO stock, worth $283,634. This represents 0.0% of its overall portfolio holdings.

Number of Shares
167,831
Previous 145,717 15.18%
Holding current value
$283,634
Previous $878,000 65.26%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.81 - $8.13 $40,026 - $179,786
22,114 Added 15.18%
167,831 $305,000
Q2 2024

Aug 13, 2024

BUY
$5.84 - $17.56 $109,091 - $328,020
18,680 Added 14.7%
145,717 $878,000
Q1 2024

May 15, 2024

BUY
$10.95 - $16.79 $1.39 Million - $2.13 Million
127,037 New
127,037 $1.42 Million
Q4 2023

Feb 12, 2024

BUY
$4.81 - $15.38 $388,109 - $1.24 Million
80,688 New
80,688 $1.2 Million
Q3 2022

Nov 14, 2022

SELL
$8.23 - $15.14 $8.89 Million - $16.4 Million
-1,080,515 Reduced 95.78%
47,586 $455,000
Q2 2022

Aug 15, 2022

SELL
$5.89 - $19.46 $9.91 Million - $32.7 Million
-1,681,725 Reduced 59.85%
1,128,101 $9.13 Million
Q1 2022

May 16, 2022

SELL
$13.65 - $22.06 $12.5 Million - $20.3 Million
-918,504 Reduced 24.64%
2,809,826 $47.5 Million
Q4 2021

Feb 11, 2022

SELL
$21.49 - $74.4 $2.98 Million - $10.3 Million
-138,812 Reduced 3.59%
3,728,330 $80.1 Million
Q3 2021

Nov 15, 2021

BUY
$52.51 - $80.91 $50.9 Million - $78.5 Million
970,252 Added 33.49%
3,867,142 $286 Million
Q2 2021

Aug 16, 2021

BUY
$52.2 - $75.23 $12.3 Million - $17.7 Million
235,328 Added 8.84%
2,896,890 $158 Million
Q1 2021

May 17, 2021

BUY
$62.84 - $87.68 $42.6 Million - $59.5 Million
678,456 Added 34.21%
2,661,562 $196 Million
Q4 2020

Feb 12, 2021

BUY
$34.11 - $112.26 $32.4 Million - $106 Million
948,578 Added 91.69%
1,983,106 $171 Million
Q3 2020

Nov 16, 2020

BUY
$29.36 - $47.1 $30.4 Million - $48.7 Million
1,034,528 New
1,034,528 $39 Million

Others Institutions Holding ALXO

About ALX ONCOLOGY HOLDINGS INC


  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $68.9M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.